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Coxsackie A virus is one of the major pathogens associated with hand, foot and mouth disease (HFMD). The etiological char-
acteristics of Coxsackie A virus type 16 (CA16) are thought to correlate with the pathological process of its infection. Two 
CA16 strains that were isolated from a severe HFMD patient presented with different plaque forms. This observation, along 
with biological analysis, indicated that the differences in the strains’ biological characteristics, such as proliferation kinetics 
and immunogenicity, correlate with differences in their pathogenicity toward neonatal mice. Furthermore, these differences are 
thought to be associated with the sequence of the 5′ non-coding region of the viral genome and the VP1 structural region se-
quence. The results suggest that the biological and genetic characteristics of the CA16 viral strains are relevant to their patho-
genicity. 
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Hand, foot and mouth disease (HFMD) is responsible for 
large epidemics in Asia and the Pacific [1–3]. The etiology 
of this viral disease, which mainly infects children, is un-
clear. Among the varieties of enteric viruses that could 
cause HFMD [4–6], EV71 and CA16 are the two major 
disease-causing pathogens [6,7]. Preliminary pathogen de-
tection in infected cases suggests that EV71 is responsible 
for 49%–52% [8,9] of reported cases, while CA16 is re-
sponsible for approximately 45%–48% [8,9]. Although re-
cent studies indicate that most severe and fatal cases of 
HFMD are caused by EV71 [10], several in-depth studies 
have demonstrated that, apart from causing a large number 
of ordinary HFMD cases, which behave as typical oral mu-
cosa herpes or hand and foot herpes accompanied by related 
symptoms, CA16 may also lead to a small number of severe 
cases. In addition, damage to the central nervous system is a 
pathological feature of CA16 infection [11,12]. Therefore, it 
is important to further investigate the etiological features of 
CA16 in the context of the prevention and control of HFMD. 
Our early work focused on etiology of HFMD epidemics at 
Fuyang, Anhui, China in 2008. An etiological analysis of 
CA16 strains from other HFMD epidemiological areas was 
conducted in the following years [13]. We isolated and col-
lected different CA16 strains from HFMD patients and per-
formed etiological studies. The biological phenotypic char-
acteristics of one CA16 virus sample isolated from a severe 
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HFMD patient from Guangxi in 2010 suggested that two 
phenotypic strains are involved in the tissue-culture process. 
The two strains present different proliferation kinetics and 
lesion capacity in sensitive animals. The differences may be 
related to minor base pair mutations on the 5′ non-coding 
region, the VP1 region, and the 3′ non-coding region. Such 
phenotypic characteristic and genome structural differences 
may lead to significant differences in the course of CA16 
infections and relevant pathological results, e.g., the severi-
ty of HFMD pathological changes. Accordingly, these dif-
ferences require further investigation to determine the 
CA16-related mechanisms leading to HFMD, the epidemi-
ological characteristics of CA16 infection, and for therapy 
and vaccine development. 
1  Materials and methods 
1.1  Cells 
Vero cells (ATCC, qualified for vaccine manufacture) were 
cultured at 37C in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 5% fetal calf serum.  
1.2  Viral isolation and culture 
CA16 virus was isolated from the throat swab of a Guangxi 
HFMD patient in 2010. The viral samples were diluted in 
0.01 mol L1 PBS (pH 7.2) and filter-sterilized using a 
0.22-m filter (Millipore, Bedford, MA) before being used 
to infect Vero cells. Samples were collected after the ob-
servation of cytopathic effects (CPE), and the viral titer was 
determined for further studies. 
1.3  Plaque cloning and passaging of viral strains 
Monolayers of Vero cells in a 6-well tissue culture plate 
were incubated with serially diluted virus preparation for 20 
min. The cells were overlaid with nutrient agarose and cul-
tured for 4–5 d. Typical plaques were selected and inocu-
lated into flasks (DMEM Medium containing 5% FBS). The 
supernatants were harvested when the CPE reached 95%. 
After two rounds of plaque cloning, the selected viral clones 
were inoculated into a monolayer of Vero cells for continu-
ous subcultures.  
1.4  Viral titration 
The viral stocks were serially diluted 10 times using se-
rum-free viral dilution buffer, and 100 L of the diluted 
stocks were added to each of the 96-well plates, which had 
previously been coated with 80%-confluent Vero cells. 
Overall, 8 parallel wells for each dilution stock were used. 
The 96-well plates were incubated at 37C in a 5% CO2 
incubator for 5–7 d to observe the virus’s cytopathicity. The 
50% cell culture infective dose (CCID50) was determined by 
Reed-Muench assay. 
1.5  Viral cross-neutralization test  
G20-M and G20-D strains obtained from plaque clones 
were used to immunize mice to prepare specific antiserum. 
The harvested viral G20-M and G20-D preparations were 
diluted to 2×103 CCID50 mL
–1 with maintaining buffer, and 
50 L of the diluted viral stocks was added to each of the 
96-well plates. In addition, the anti-G20-M and anti-G20-D 
serum were serially diluted, i.e., in ratios of 1:8, 1:16, 1:32, 
1:64, 1:128, 1:256, 1:512, and 1:1024. Fifty-microliters 
of the serially diluted anti-G20-M serum was added into 
each well of the 96-well plates containing the G20-M and 
G20-D strains. After incubation of the virus and serum to-
gether for 2 h, Vero cells were added, before an additional 
5–7 d incubation to observe the neutralization effect. The 
same operation was performed with serially diluted G20-D 
serum.  
1.6  Neonatal mice test and pathological analysis 
One-day-old specific pathogen free (SPF) level imprinting 
control region (ICR) neonatal mice (weight 1.8–2.0 g, pro-
vided by the Experimental Animal Center, Institute of 
Medical Biology, Chinese Academy of Medicine Sciences) 
were randomly divided into blank control, G20-M, and 
G-20D groups with three litters per group and 10–13 neo-
natal mice per litter. The neonatal mice in the virus groups 
were injected intracerebrally with two different viral strains 
(104 CCID50), while the control group mice were injected 
with PBS. Appetite changes, activities, mental status, limb 
paralysis, and dying or death symptoms were observed for 7 
d post-injection. Dead mice presenting obvious pathological 
features were sampled. Their brain and lung tissues were 
taken and fixed in 10% aldehyde solution for 3–5 d. Neona-
tal mouse brain tissue lesions were observed using micros-
copy after dehydration, paraffin embedding, sectioning, 
hematoxylin/eosin (HE) staining, and cementing.  
1.7  Preparation of immunized animal serum 
Neonatal mice were immunized via abdominal subcutane-
ous multi-point injection of purified two viral strains (106.5 
CCID50) mixed with Freund’s incomplete adjuvant, while 
the control group was injected with PBS. Mice were im-
munized through a 0- and 4-week program. Tail blood col-
lection was followed by two immunizations and serum col-
lection. 
1.8  Viral gene PCR and sequence analysis  
Total RNA was extracted from the harvested viral superna-
tant and pathological tissues using a TRNzol-A+ total RNA 
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extraction kit (Tiangen, China).  
Primers were designed to amplify the 5′ and 3′ ends of 
the viral genome along with the VP1 region of human Cox-
sackie virus A16 strain KMM/08 (gi|330375630). PCR am-
plification was performed using the PremSTAR MAX Pre-
mix system (Takara, Japan), following the manufacturer’s 
protocol. PCR sequences of three regions of G20-M and 
G20-D were obtained and bi-directionally sequenced by 
TIANGEN. The aligned sequences were analyzed using 
OMIGA software. The amplification and sequencing were 
repeated three times. 
The PCR primer sequences used were as follows:  
G20 5′ non-coding region primers: 5′ UNRf (1–23) 5′- 
TGAAACAGCCTGTGCCTTGTTC-3′, 5′ UNRr (835–856) 
5′-TATGCATCCTTGTAGTAGTTTA-3′; 
G20 3′ non-coding region primers: 3′ UNRf (6981–7004) 
5′-AGAACTGGTAAAGAGTATGGATTG-3′, 3′ UNRr  
(7397–7416) 5′-GCTATTCTGGTTATAACAAA-3′; 
VP1 structural protein primers: VP1f (2320–2350) 5′- 
TGTCGTACCCATTGGTGCTCCCACT-3′, VP1r (3440– 
3470) 5′-AGTGGTGGAAGAGACTAACAAGTCCCTA-  
GA-3′. 
For quantitative real-time PCR (qRT-PCR), the One-Step 
PrimeScript™ RT-PCR Kit (TaKaRa, Japan) was used ac-
cording to the manufacturer’s protocol. A CA16 nucleic 
acid standard was serially diluted to 105, 104, 103, 102, and 
10 copies L1 and added into the same reaction plate for 
the PCR reaction. Primers and probes designed using the 
VP1 conserved region sequences of the G20 strain were as 
follows:  
Vp1f: 5′-CTAGTAGTCACAGATTAGGCACTGGTG-3′; 
Vp1r: 5′-CATTGTGATGATGCTGACAAGACC-3′; Probe 
(2411–2438): 5′-FAM-CGTCTAATGCTAGCGACAATA- 
MRA-3′. 
1.9  Analysis of G20-M and G20-D genetic distance 
The viral gene sequences of 9 CA16 strains were obtained 
from GenBank for analysis of the G20-M and G20-D 5′ 
non-coding region genetic distance. Each selected strain rep-
resented a typical epidemical strain in different areas [14–16]. 
The sequences were analyzed, and an evolutionary tree 
was drawn using EditSeq and MegAlign in DNAstar.  
1.10  Data analysis  
The G20-D and G20-M proliferation kinetics data were  
collected three times at 37°C and 39.5°C, before being ana-
lyzed statistically. For the statistical analysis, non-parametric 
tests were used to analyze the data from the 37°C experi-
ments. The P value of the infectious titer was 0.00, and the 
P value of the qRT-PCR was 0.0058. Student’s t-test was 
used to analyze the 39.5°C data. With a t value of 13.2873, 
the P value was 0.00. All P values were <0.05 and thus 
were considered to be statistically significant. 
2  Results 
2.1  Isolation of two CA16 viral strains and their bio-
logical phenotype characteristics 
After a preliminary analysis of more than 40 CA16 viral 
strains from a variety of areas in mainland China, we chose 
31 samples and adopted Vero cells for passaged prolifera-
tion. We observed significantly higher titers for G20 prolif-
eration in cells compared with other strains. Phenotypic 
analysis of harvested viral supernatants of plaques from 
those Vero cells used to proliferate the strains suggested 
that there were two different phenotypic G20 strains (Figure 
1). One strain presents larger and irregular plaques, and the 
other presents smaller plaques (Figure 1). Sequence analysis 
of the 5′ non-coding region, 3′ non-coding region, and VP1 
coding region of 10 plaques selected from the two strains 
confirmed that there were two different strains, which were 
subsequently named G20-D and G20-M.  
2.2  Proliferation kinetics of two CA16 strains 
Based on the viral isolation and phenotypic analysis results, 
G20-D and G20-M were proliferated in Vero cells and ana-
lyzed for strain proliferation kinetics. The same multiplicity 
of infection (MOI; 0.05) was used to inoculate Vero cells 
along with the time sampling for an infectious viral titration 
test. The results indicated that the G20-D strain has a higher 
proliferation rate than the G20-M strain in Vero cells. Sta-
tistically different values were obtained after 24 h of infec-
tion (Figure 2A). Dynamic infection analysis using 
qRT-PCR also supported this observation (Figure 2B). To 
further confirm the proliferation differences of the two 
strains and their biological characteristics, we took ad-
vantage of the fact that different strains of enterovirus pro-
liferate differently under a relatively high incubation tem-
perature [17]. We observed the proliferation kinetics of the 
two strains at 39.5°C. The results suggested that G-20 M 
did not proliferate at 39.5°C, while significant proliferation  
 
 
Figure 1  Phenotypic differences between two CA16 strains: G20-D and 
G20-M. Plaque morphology of strains G20-D (large plaque) and G20-M  
(small plaque) stained with 0.5% crystal violet dye. 
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Figure 2  Comparison of infection kinetics of strains G20-D and G20-M on Vero cells. A, Growth kinetics (viral titer) of G20-D and G20-M on Vero cells 
at 37°C (from three biological replicates). B, Growth kinetics (viral load) of G20-D and G20-M on Vero cells at 37°C (qRT-PCR repeated three times). C, 
Growth kinetics (viral titer) of G20-D and G20-M on Vero cells at 39.5°C (from three biological replicates). Vero cells were infected by the virus at an MOI 
of 0.05. The fluid samples were collected at different time points and viral titer or viral load (genomic copies) were examined by titration or qRT-PCR, 
respectively. 
was observed for the G-20D strain (Figure 2C).  
2.3  Comparison of the pathogenicity of the two strains 
in neonatal mice  
An earlier study demonstrated that CA16 virus is pathogen-
ic to neonatal mice [18]. This pathogenicity has been used 
as a phenotype-defining feature of CA16 [18] and as a 
comparative indicator between different genotypes or 
strains. Comparing the pathogenicity of the G20-D and 
G20-M strains would permit observation of fundamental 
biological features of the two strains. Each of the two 
strains was intracerebrally injected (104 CCID50) into neo-
natal mice. G20-D was observed to be pathogenic to neona-
tal mice, with a 7-d post-infection death rate that exceeded 
50% (Figure 3C). The comparative G20-M death rate was 
lower than 5% (Figure 3C). The neonatal mice first dis-
played paralysis of hind limbs, followed by death within 
one day. Further histological examination of the pathologi-
cal changes indicated that infection with the G20-D strain 
might cause dissolution of glial cells, nuclei rupture, intra-
ventricular hemorrhage, and the formation of glial nodules 
in the brain tissue of neonatal mice (Figure 3A and B). In-
terestingly, G20-D infection in the neonatal mouse brain 
also causes obvious lung tissue lesions, including the swell-
ing and bleeding of the alveolar cavity, and alveolar tissue 
destruction (Figure 3D and E). Moreover, viral analysis to 
ensure such lesions was related to viral infection (viral titra-
tion and qRT-PCR), demonstrating that the bleeding brain 
lesions of G20-D-infected mice were accompanied by viral 
proliferation (104.5 CCID50, Figure 3F). The tissues that 
displayed pulmonary congestion and alveolar hemorrhage 
presented 101.5 CCID50 virus (Figure 3F). In contrast, in the 
G20-M group, only two neonatal mice died among the three 
infected litters (10–13 mouse per litter). Pathological studies 
of the brain and lung tissues of the two mice indicated only 
mild inflammatory cell aggregation in brain tissue, mild 
hyperemia of the alveolar wall, and infiltration of inflam-
matory cells (Figure 3G and H). At the same time, 102.5 
CCID50 of virus was detected in the brain tissue, while no 
virus was detected in the lung tissue (Figure 3I). These re-
sults suggest significant differences between the two strains 
in terms of animal pathogenicity. 
2.4  Immunogenicity of the two strains and the cross-    
neutralizing capacity of strain-induced antibodies 
To further understand the biological phenotypes of the 
G20-D and G20-M strains, we used identical amounts of 
virus (106.5 CCID50) mixed with Freund’s incomplete adju-
vant to immunize mice by intramuscular injection. Serum 
was sampled after two immunizations with a 0 and 4 week 
program. Serum neutralization titer was measured using 100 
CCID50 viral doses. The results indicated that the two strains 
induced neutralized antibodies with different titers against  
the inducing viral strain. When neutralizing the other 
340 Yang E X, et al.   Sci China Life Sci   April (2012) Vol.55 No.4 
 
Figure 3  Analysis of pathogenicity of G20-D and G20-M in neonatal mice. A and B, Pathological changes induced by G20-D in neonatal brain tissue 
(×200). Intraventricular hemorrhage and the formation of glial nodules are indicated by a green arrow and a black arrow, respectively. C, Comparison of 
induced death rate in neonatal mice infected by G20-D and G20-M. D and E, Pathological changes induced by G20-D in neonatal lung tissue (×200). Hy-
peremia and hemorrhage of alveolar wall and cavity and mild autolysis of the alveolar tissue (FI) are indicated by a green arrow and a black arrow, respec-
tively. F, Virus titration of brain and lung tissues of G20-D lethal neonatal mice. Titration by tissue culture and qRT-PCR were performed to examine the 
brain and lung tissues of 30 lethal neonatal mice. G, Pathological changes of the brain tissue in G20-M lethal neonatal mice (×200), showing mild inflamma-
tion cell aggregation. H, Pathological changes of lung tissue in G20-M lethal neonatal mice (×200), showing mild hyperemia of the alveolar wall and some 
inflammatory cell filtration (green arrow). I, Virus titration of brain and lung tissue in G20-M lethal neonatal mice. Brain and lung tissues from two mice  
were sampled and examined by viral titer. B-E, G, and H are HE staining results. 
strain using the same titer, the strains displayed significant 
differences. Among these differences, the G20-D-induced 
neutralization antibody showed a 1:16 neutralization titer to 
G20-D, but 1:512 to G20-M for the same dosage of 100 
CCID50. Conversely, the G20-M-induced neutralization 
antibody presented a 1:16 neutralization titer to the G20-M 
strain and a 1:8 to the G20-D strain. The results indicate the 
two strains have significant differences in their immuno-
genicity. 
2.5  Comparison of gene sequences of the two pheno-
typically different strains 
Based on the analysis of different biological features of 
G20-D and G20-M and according to the basic principles of 
biological characteristics and related gene sequences of en-
teroviruses [19–21], we decided to sequence the 5′-non-    
coding region, the 3′ non-coding region, and the VP1 cod-
ing region. We repeated the sequencing three times and 
aligned the sequence (Figure 4A). Comparison of the three 
gene regions from the two strains revealed individual nu-
cleotide difference in all three regions. Seven different nu-
cleotides were observed within the 5′ non-coding region 
(Figure 4A). The G20-D strain has an A at position 33, but 
the G20-M has a G, while the same difference is observed at 
site 35. G20-D has a T at position 36, while G20-M has a G. 
There is a T at position 37 in G20-D but an A in G20-M. 
There is a nucleotide missing at position 44 of G20-D. In 
addition, G20-D has a T, while G20-M has a C at position 
110, and at position 212, G20-D has a C and G20-M has a T. 
Three-nucleotide differences were observed in the 3′ 
non-coding regions (Figure 4A). At position 52, G20-D has 
a C, but G20-M has a G. There is one nucleotide missing at 
position 90 for G20-D, and at position 312, G20-D has a T, 
but G20-M has a C. The sequence analysis of the 
VP1-coding region indicated that nucleotide differences led 
to three amino acid differences between the two strains 
(Figure 4A). G20-D has an M, but G20-M has a T at amino 
acid 98. At amino acid 240, G20-D has a T, while G20-M 
has an I. At amino aid 248, G20-D has a T, but G20-M has 
an A. The nucleotide differences in both the coding and 
non-coding regions (Figure 4A) suggest that the biological 
differences between the two strains are based on their ge-
netic structures. In addition, these strains’ sequences pro- 
vide clues for further studies of loci related to proliferation 
efficiency, pathogenicity to animals, and immunogenicity 
between different strains. The evolutionary tree drawn using 
VP1 and the 5′ non-coding region indicates that, although  
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Figure 4  Sequence comparison of 5′-end, 3′-end, and VP1 coding region in strains G20-D and G20-M. A, Comparison of the 5′- non-coding region, 3′- 
non-coding region, and amino acid sequences of VP1 structural protein between G20-M and G20-D (each of the three regions within the two strains was 
sequenced three times independently and aligned with the same result). B, Phylogenetic analysis of G20-M and G20-D, based on the sequence of CA16 5’-  
non-coding region. C, Phylogenetic analysis of G20-M and G20-D, based on the sequence of CA16 VP1. 
the two strains have only a few differences, they both be-
long to different sub-genotypes of the B genotype (Figure 
4B and C). 
3  Discussion 
Early studies of enteroviruses showed that as an enterovirus, 
CA16 is pathogenic to humans [22,23]. CA16 can cause 
herpes pharynx inflammation, HFMD, and viral encephalitis 
under certain conditions [12,24]. The virus has three geno-
types: A, B and C [9]. Relevant epidemiological analyses 
suggest that the main phenotype in China is B [16]. In-
creasing attention is being paid to CA16 as a pathogenic 
cause of HFMD pandemics, in addition to EV71, in recent 
studies [25,26]. Several reports indicate that CA16 causes 
mild HFMD and is responsible for general hand, foot and 
mouth herpes and flu-type symptoms [27]; however, other 
reports suggest that CA16 can cause severe cases and can 
affect the nervous system. However, the mechanism of in-
fection and pathological consequences remain unclear [28]. 
Therefore, investigating the biological characteristics of 
different CA16 strains from an etiological point of view 
could aid in understanding the differences between diseases 
caused by the virus and provide information concerning its 
pathological mechanisms.  
The two different strains described in this paper are from 
the throat swab secretions from the same patient. Although 
our observation of the viral biological features is based on 
second-generation virus proliferated in Vero cells, the 
source of the two strains might be genetic mutations, either 
from the same infected individual or from in vitro prolifera-
tion. Although we have not proven either of the two possi-
bilities or their related infectious biological mechanisms to 
date, the comprehensive comparison of the two strains still 
clearly showed that even within the same genotype, there 
are strains that present different biological characteristics. 
The differences are based on genetic structures within the 5′ 
and 3′ non-coding regions and VP1 coding regions and are 
responsible for the observed proliferation kinetics differ-
ences. Previous data suggested that specific sequence ele-
ments on enterovirus 5′ and 3′ non-coding regions are es-
sential for regulation of viral proliferation. Studies on po-
liovirus have shown that a change in the 480-nucleotide 
region can directly affect the pathogenicity of the virus [29]. 
In our work, seven nucleotide changes in the 5′ non-coding 
region and the three in the 3′ non-coding region between 
G20-D and G20-M were not same as those detailed in pre-
vious studies. It is unclear if these sequences are essential 
regulatory elements for viral proliferation in the CA16 viral 
genome; however, our study provided a sound basis for 
further studies. In addition, the differences in immunogenic-
ity of the two strains and changes at specific sites in the 
VP1 coding regions also provide a foundation for further 
study of the immunogenicity and gene regulatory sites of 
CA16. Interestingly, our observations of the changes in 
gene sequences could lead to obvious differences in the 
formation of animal lesions by specific virus strains. Intrac-
erebral injection of the G20-D strain in neonatal mice not 
only caused obvious damage to neuronal cells in the brain, 
but also caused the formation of glial nodules that lead to 
paralysis of the hind limbs. In the infection process, conges-
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tion and edema of lung tissues filled the alveolar space with 
secretions, resulting in loss of function. Although we do not 
know the direct cause of death of the neonatal mice from 
pathological examinations, the severe congestion and edema 
in the alveolar space obviously cannot be ignored. Viral 
tests of brain and lung tissue suggested that the latter had 
only a very low viral load. These results suggest the direct 
cause of death in severe HFMD patients infected by CA16 
and EV71 is neurogenic pulmonary edema and loss of car-
diopulmonary functions [30]. If the connection is confirmed, 
it will clarify the pathological manifestations of mild and 
severe HFMD from an etiological point of view. These con-
clusions are based on the possibility, as observed in CA16 
infectious epidemiological studies that elicited no obvious 
serum antibody response [31], that etiological evidence was 
still presented. In addition, these results will aid CA16 vac-
cine research and development. The biological characteris-
tics of the two strains observed in this study might relate to 
the structural differences caused by gene sequence differ-
ences. However, the direct relationship between the specific 
gene sequences and the related symptom changes is uncer-
tain, although the data does provide clues for further research. 
Indeed, additional studies are underway, using mutant virus 
sequences to locate CA16 biological features, especially 
those that relate to changes in animal pathogenicity. 
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